Since ImCheck was founded in 2015, it has participated in 8 rounds of funding. In total ImCheck has raised $211.5M. ImCheck's last funding round was on Aug 2024 for a total of $22.5M.
ImCheck has 17 investors, including Invus, The Leukemia & Lymphoma Society Therapy Acceleration Program and Kurma Partners. The latest investment occurred in Aug 2024.